Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

KERX

Keryx Biopharmaceuticals, Inc. (delisted) (KERX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:KERX
DataOraFonteTitoloSimboloCompagnia
26/12/201814:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
26/12/201812:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201822:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201821:54Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201815:20Edgar (US Regulatory)Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201815:09Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201814:25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201813:49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201813:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
12/12/201822:42Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
11/12/201818:00GlobeNewswire Inc.Keryx Biopharmaceuticals Stockholders Approve Merger with Akebia TherapeuticsNASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
03/12/201822:09Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
30/11/201814:55GlobeNewswire Inc.Glass Lewis Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics...NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
29/11/201813:00GlobeNewswire Inc.ISS Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia TherapeuticsNASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
15/11/201823:15Business WireAkebia Therapeutics and Keryx Biopharmaceuticals Announce Chairperson for Combined CompanyNASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/11/201812:07Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
08/11/201822:30GlobeNewswire Inc.Keryx Biopharmaceuticals Announces Third Quarter 2018 Financial ResultsNASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
06/11/201822:30GlobeNewswire Inc.Keryx Biopharmaceuticals to Release Third Quarter 2018 Financial Results on Thursday, November 8, 2018NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
30/10/201822:31GlobeNewswire Inc.Keryx Biopharmaceuticals Announces Filing of Definitive Joint Proxy Statement in Connection with Pending Merger with Akebia T...NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
30/10/201822:28Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
01/10/201815:16GlobeNewswire Inc.Keryx Biopharmaceuticals Announces Participation in an Upcoming Investor ConferenceNASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
24/09/201821:31Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
09/08/201822:21Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
08/08/201813:00GlobeNewswire Inc.Keryx Biopharmaceuticals Announces Second Quarter 2018 Financial Results   NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
02/08/201822:05GlobeNewswire Inc.Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2018 Financial Results on Wednesday, August 8, 2018NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
30/06/201801:12PR Newswire (US)WeissLaw LLP Investigates Keryx Biopharmaceuticals Inc.NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
29/06/201822:29Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
28/06/201813:00Business WireAkebia Therapeutics & Keryx Biopharmaceuticals to Merge, Creating a Fully Integrated Company Focused on the Development & Com...NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
20/06/201815:21GlobeNewswire Inc.Keryx Biopharmaceuticals Announces Participation in a Renal Disease Panel at the JMP Securities Life Sciences Conference on T...NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
31/05/201822:14Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:KERX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network